Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

NVTA | Invitae Corp

IndexRUT P/E- EPS (ttm)-3.23 Insider Own2.22% Shs Outstand267.01M Perf Week-12.75%
Market Cap179.52M Forward P/E- EPS next Y-1.04 Insider Trans-2.91% Shs Float261.08M Perf Month-22.28%
Income-799.67M PEG- EPS next Q-0.31 Inst Own61.61% Short Float / Ratio15.06% / 3.98 Perf Quarter-38.88%
Sales493.88M P/S0.36 EPS this Y39.55% Inst Trans-9.47% Short Interest39.31M Perf Half Y-47.88%
Book/sh-0.75 P/B- EPS next Y21.47% ROA-41.94% Target Price2.03 Perf Year-73.74%
Cash/sh1.22 P/C0.55 EPS next 5Y17.01% ROE-863.95% 52W Range0.67 - 3.78 Perf YTD-63.85%
Dividend- P/FCF- EPS past 5Y-37.83% ROI-58.77% 52W High-82.19% Beta1.75
Dividend %- Quick Ratio2.83 Sales past 5Y53.81% Gross Margin21.92% 52W Low0.35% ATR0.07
Employees1700 Current Ratio2.97 Sales Q/Q-11.78% Oper. Margin-113.39% RSI (14)29.50 Volatility5.99% 9.72%
OptionableYes Debt/Eq- EPS Q/Q92.80% Profit Margin-161.92% Rel Volume1.41 Prev Close0.67
ShortableYes LT Debt/Eq- EarningsAug 08 AMC Payout- Avg Volume9.89M Price0.67
Recom3.91 SMA20-19.82% SMA50-36.51% SMA200-55.15% Volume6,118,080 Change0.35%
Date Action Analyst Rating Change Price Target Change
Jul-05-23Resumed JP Morgan Underweight
May-15-23Downgrade Raymond James Mkt Perform → Underperform
Jan-31-23Downgrade Goldman Neutral → Sell $2
Aug-25-22Initiated Credit Suisse Underperform $1
Aug-10-22Downgrade JP Morgan Neutral → Underweight
Jul-26-22Downgrade Cowen Outperform → Market Perform $8 → $2.50
Jul-21-22Downgrade Raymond James Outperform → Mkt Perform
Jul-20-22Downgrade Ladenburg Thalmann Buy → Neutral
Jul-19-22Downgrade The Benchmark Company Buy → Hold
Jul-19-22Downgrade SVB Leerink Outperform → Mkt Perform
Sep-22-23 04:30PM
Sep-21-23 05:00AM
Sep-19-23 01:13PM
Sep-14-23 02:00PM
09:37AM Loading…
Aug-30-23 09:37AM
Aug-28-23 04:02PM
Aug-24-23 12:33PM
Aug-15-23 07:30AM
Aug-14-23 04:02PM
Aug-11-23 08:00AM
Aug-09-23 02:00AM
Aug-08-23 05:50PM
04:45AM Loading…
Jul-28-23 04:45AM
Jul-26-23 04:01PM
Jul-21-23 12:00PM
Jun-26-23 05:30AM
Jun-14-23 11:40AM
Jun-08-23 06:19AM
Jun-05-23 02:00PM
May-31-23 06:59AM
May-26-23 08:01AM
May-25-23 07:00PM
May-15-23 04:27PM
May-11-23 02:01PM
08:30PM Loading…
May-09-23 08:30PM
Apr-26-23 06:59AM
Apr-21-23 09:52PM
Apr-17-23 04:30PM
Apr-13-23 08:45AM
Mar-28-23 10:10AM
Mar-22-23 07:30AM
Mar-21-23 07:30AM
Mar-16-23 07:30AM
Mar-15-23 05:30PM
Mar-06-23 07:30AM
Mar-01-23 04:05PM
Feb-28-23 11:00PM
Feb-23-23 10:07AM
Feb-16-23 07:00AM
Feb-14-23 07:00AM
Feb-13-23 01:59PM
Feb-09-23 08:15AM
Feb-08-23 08:53AM
Feb-03-23 01:19PM
Jan-30-23 07:30AM
Jan-19-23 11:45AM
Jan-12-23 11:03AM
Jan-09-23 07:00AM
Jan-04-23 08:41AM
Dec-21-22 06:05AM
Dec-20-22 07:30AM
Dec-19-22 05:15PM
Dec-17-22 06:30AM
Dec-16-22 04:00PM
Dec-07-22 07:30AM
Dec-05-22 03:49PM
Dec-01-22 07:30AM
Nov-29-22 10:07AM
Nov-15-22 08:11PM
Nov-12-22 06:00AM
Nov-10-22 10:13AM
Nov-09-22 11:30AM
Nov-08-22 09:00PM
Nov-05-22 09:45AM
Nov-03-22 05:15PM
Oct-31-22 05:13PM
Oct-30-22 08:00AM
Oct-28-22 11:16AM
Oct-27-22 07:30AM
Oct-25-22 04:05PM
Oct-19-22 09:55AM
Oct-03-22 11:43AM
Sep-27-22 07:30AM
Sep-23-22 02:35PM
Sep-22-22 11:00AM
Sep-21-22 11:09AM
Sep-20-22 08:30AM
Sep-15-22 04:00PM
Sep-13-22 06:25PM
Sep-12-22 07:30AM
Sep-07-22 10:26AM
Sep-06-22 11:18AM
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nussbaum Robert LChief Medical OfficerJun 13Sale1.387,0869,757569,345Jun 15 04:58 PM
Brida ThomasSee RemarksJun 13Sale1.387,0799,748704,087Jun 15 04:57 PM
Wen YafeiChief Financial OfficerMay 16Sale1.9943,45286,600700,297May 18 04:17 PM
Knight Kenneth D.Chief Executive OfficerMay 16Sale1.2045,43254,4871,671,610May 18 04:20 PM
Brida ThomasSee RemarksMay 16Sale1.2026,47631,753711,166May 18 04:14 PM
Nussbaum Robert LChief Medical OfficerMay 16Sale1.2026,47631,753576,431May 18 04:18 PM
WERNER ROBERT F.Chief Accounting OfficerMay 16Sale1.2021,55925,856354,748May 18 04:15 PM
Wen YafeiChief Financial OfficerMar 13Sale1.412,6253,701443,749Mar 15 04:22 PM
Brida ThomasSee RemarksMar 13Sale1.412,6253,701437,642Mar 15 04:36 PM
Nussbaum Robert LChief Medical OfficerMar 13Sale1.412,6253,701447,907Mar 15 04:23 PM
Knight Kenneth D.Chief Executive OfficerMar 13Sale1.411,8532,613517,042Mar 15 04:22 PM
George Sean EDirectorDec 19Sale2.0811,16323,210732,677Dec 20 09:00 PM
George Sean EDirectorDec 16Sale2.0444,81691,420743,840Dec 20 09:00 PM